Patent delisted for IMPAX drug TWINJECT 0.15
Annual Drug Patent Expirations for TWINJECT+0.15 Twinject 0.15 is a drug marketed by Impax and is included in one NDA. […]
Patent Expiration
Patent delisted for IMPAX drug TWINJECT 0.3
Annual Drug Patent Expirations for TWINJECT+0.3 Twinject 0.3 is a drug marketed by Impax and is included in one NDA.
Patent delisted for Abbvie drug NORVIR
Annual Drug Patent Expirations for NORVIR Norvir is a drug marketed by Abbott, Abbvie, and Abbvie Inc and, and is
New patent expiration for Arbor Pharms drug BIDIL
Annual Drug Patent Expirations for BIDIL Bidil is a drug marketed by Arbor Pharms Llc and is included in one
New patent expiration for Arbor Pharms drug BIDIL Read Post »
Drug Patent Expirations for the Week of September 6, 2020
DEXYCU KIT (dexamethasone) Eyepoint pharms Patent: 10,022,502 Expiration: Sep 12, 2020 See More … For more information on how DrugPatentWatch
Drug Patent Expirations for the Week of September 6, 2020 Read Post »
Patent delisted for Boehringer Ingelheim drug TRIJARDY XR
Annual Drug Patent Expirations for TRIJARDY+XR Trijardy Xr is a drug marketed by Boehringer Ingelheim and is included in one
Patent delisted for Boehringer Ingelheim drug TRIJARDY XR Read Post »
Patent delisted for Boehringer Ingelheim drug OFEV
Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA.
Patent delisted for Boehringer Ingelheim drug OFEV Read Post »
Patent delisted for Boehringer Ingelheim drug GLYXAMBI
Annual Drug Patent Expirations for GLYXAMBI Glyxambi is a drug marketed by Boehringer Ingelheim and is included in one NDA.
Patent delisted for Boehringer Ingelheim drug GLYXAMBI Read Post »
Patent delisted for Veloxis Pharms drug ENVARSUS XR
Annual Drug Patent Expirations for ENVARSUS+XR Envarsus Xr is a drug marketed by Veloxis Pharms Inc and is included in
Patent delisted for Veloxis Pharms drug ENVARSUS XR Read Post »
